AU2001278849A1 - Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives - Google Patents

Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives

Info

Publication number
AU2001278849A1
AU2001278849A1 AU2001278849A AU7884901A AU2001278849A1 AU 2001278849 A1 AU2001278849 A1 AU 2001278849A1 AU 2001278849 A AU2001278849 A AU 2001278849A AU 7884901 A AU7884901 A AU 7884901A AU 2001278849 A1 AU2001278849 A1 AU 2001278849A1
Authority
AU
Australia
Prior art keywords
preparationswith
tetrahydropiperine
analogues
nutrients
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001278849A
Inventor
Vladimir Badmaev
Kumar Rajinder Bammi
Muhammed Majeed
Sankaran Natarajan
Subbalakshmi Prakash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sami Chemicals and Extracts Ltd
Sabinsa Corp
Original Assignee
Sami Chemicals and Extracts Ltd
Sabinsa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sami Chemicals and Extracts Ltd, Sabinsa Corp filed Critical Sami Chemicals and Extracts Ltd
Publication of AU2001278849A1 publication Critical patent/AU2001278849A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU2001278849A 2000-05-19 2001-05-21 Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives Abandoned AU2001278849A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20524500P 2000-05-19 2000-05-19
US60205245 2000-05-19
US27797901P 2001-03-23 2001-03-23
US60277979 2001-03-23
PCT/US2001/016070 WO2001089571A2 (en) 2000-05-19 2001-05-21 Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives

Publications (1)

Publication Number Publication Date
AU2001278849A1 true AU2001278849A1 (en) 2001-12-03

Family

ID=26900240

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001278849A Abandoned AU2001278849A1 (en) 2000-05-19 2001-05-21 Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives

Country Status (6)

Country Link
US (1) US6849645B2 (en)
JP (1) JP4098985B2 (en)
AU (1) AU2001278849A1 (en)
DE (2) DE10196213B4 (en)
GB (1) GB2380675B (en)
WO (1) WO2001089571A2 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005529123A (en) * 2002-04-24 2005-09-29 リサーチ　ディベロップメント　ファンデーション Synergistic effect of nuclear transcriptional regulator NF-κB inhibitor and antitumor agent
CN1674917A (en) * 2002-06-24 2005-09-28 研究发展基金会 Treatment of human multiple myeloma by curcumin
AU2003202112A1 (en) * 2003-01-30 2004-08-23 Council Of Scientific And Industrial Research Bioavailability enhancing activity of carum carvi extracts and fractions thereof
WO2006046934A2 (en) 2003-08-26 2006-05-04 Research Development Foundation Osteoclastogenesis inhibitors and uses thereof
US20050163873A1 (en) * 2004-01-14 2005-07-28 Robert Ritch Methods and formulations for treating glaucoma
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US7780981B2 (en) 2004-09-13 2010-08-24 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US20060130675A1 (en) * 2004-11-30 2006-06-22 Crawford David S Transdermal nutritional supplement delivery patch
WO2006127905A2 (en) 2005-05-24 2006-11-30 Chrono Therapeutics, Inc. Portable drug delivery device
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
US20080138417A1 (en) * 2006-11-22 2008-06-12 Charles Grigsby Topical Composition And Method Of Forming
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
CA2994331C (en) 2015-07-31 2023-10-03 Delivra Inc. Transdermal formulations for delivery of capsaicinoids
KR102655937B1 (en) * 2016-09-27 2024-04-11 (주)아모레퍼시픽 Anti-stress composition comprising cosmoperine
EP3525825B1 (en) * 2016-10-14 2024-03-20 Cipla Limited Pharmaceutical compositions comprising rifaximin
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US20200268761A1 (en) * 2017-09-19 2020-08-27 Cipla Limited Compositions comprising ibrutinib and an alkaloid having enhanced bioavailability
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
US20200179362A1 (en) * 2018-12-05 2020-06-11 James E. Beecham Dietary supplement comprising glucuronidation inhibition assist for healthful daily synergy of anti-inflammation, cellular anti-oxidant boost, cellular protein clean-up boost
JP7163261B2 (en) * 2019-09-27 2022-10-31 富士フイルム株式会社 OIL-IN-WATER EMULSION COMPOSITION AND EXTERNAL SKIN PREPARATION
CN115670998A (en) * 2022-11-18 2023-02-03 广州澳莱娜生物科技有限公司 Acne-removing, oil-controlling and skin-brightening composition and preparation method thereof
CN115813822B (en) * 2022-12-16 2024-06-25 厦门海尼新创生物科技有限公司 High-efficiency acne-removing composition and preparation method thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH665750A5 (en) * 1982-09-30 1988-06-15 Dainippon Jochugiku Kk HEATABLE ACTIVE EVAPORATOR.
CA2136174A1 (en) * 1992-05-21 1993-11-25 Jeff J. Staggs Therapeutic uses of pungent botanicals and their related compounds
CA2098889A1 (en) * 1992-07-06 1994-01-07 Takashi Chinuki Slow-releasing medicated resin moldings and process for producing the same
EP0650728B1 (en) * 1993-10-29 2002-02-27 Council of Scientific and Industrial Research Pharmaceutical compositions containing piperine and an antituberculosis or antileprosydrug
IN176897B (en) * 1993-10-29 1996-09-28 Cadila Lab Ltd
JP2946452B2 (en) * 1994-11-04 1999-09-06 カディラ ラボラトリーズ リミテッド Composition containing piperine
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
EP0935964A1 (en) * 1998-02-12 1999-08-18 Panacea Biotec Limited Pharmaceutical compositions containing NSAIDs and piperine
GB9815177D0 (en) * 1998-07-13 1998-09-09 King S College London Treatment of skin disorders

Also Published As

Publication number Publication date
GB2380675A (en) 2003-04-16
GB2380675B (en) 2004-11-03
JP2003534295A (en) 2003-11-18
US6849645B2 (en) 2005-02-01
WO2001089571A2 (en) 2001-11-29
US20020058695A1 (en) 2002-05-16
JP4098985B2 (en) 2008-06-11
DE10196213T1 (en) 2003-04-30
WO2001089571A3 (en) 2002-03-07
GB0229561D0 (en) 2003-01-22
DE10196213B4 (en) 2020-12-17

Similar Documents

Publication Publication Date Title
AU2001278849A1 (en) Method of increased bioavailability of nutrients and pharmaceutical preparationswith tetrahydropiperine and its analogues and derivatives
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU2001270778A1 (en) Production, stabilisation and use of reduced forms of pharmaceutical compounds
AU2177001A (en) Use of indirubine derivatives for making medicines
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use
PL352293A1 (en) Derivatives of purine, method of making same and pharmaceutical compositions containing these derivatives
AU772782C (en) Cyclic peptide derivatives as inhibitors of integrin alphavbeta6
AU6359400A (en) Production of aliphatic fluorocarbons
AU2002329311A1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
HUP0303694A3 (en) Aza-amino acid derivatives and pharmaceutical
AU1036600A (en) Method for the production of quercetin and isoquercetin derivatives
PL359208A1 (en) New derivatives of quinosoline, method of production of new derivatives of quinosoline and pharmaceutical preparations
AU2001252711A1 (en) Aqueous-prodrug compound comprising moiety of paclitxel or derivatives thereof, method of preparing same and pharmaceutical composition comprising same
AU2003294762A1 (en) Film-type preparations for transmucosal administration of nicotine and method for the production thereof
MXPA03004938A (en) Process and ester derivatives for preparation of cephalosporins.
AU2001252741A1 (en) Pharmaceutical composition containing itraconazole with gastric ph-independentlyimproved solubility and preparation method thereof
SI1581258T1 (en) Pharmaceutical formulation and a method of making same
AU2570001A (en) Pharmaceutical composition and method for its manufacture
AU2003251303A1 (en) Pharmaceutical products and methods of manufacture
AU6046900A (en) Method for increasing the solubility of morphine and pharmaceutical compositionsprepared therefrom
AU2001269190A1 (en) Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them
AU2001220267A1 (en) Novel 1beta-methylcarbapenem derivatives and process of preparation thereof
AU3476300A (en) Improved mouse and method of using
AUPQ916700A0 (en) A method of preparing a pharmaceutical composition